Name droppers: Academy adds four from UCD
Shares
Four professors from UC Davis have been elected as members of the American Academy of Arts and Sciences. Established in 1780, the academy includes Americans with accomplishments in a wide range of fields, including scientists, artists, performers, poets and political leaders.
The newly elected members from UCD are
Robert Feenstra of the department of economics, College of Letters and Science;
Jodi Nunnari or the department of molecular and cellular biology, College of Biological Sciences;
Andrés Reséndez of the department of history, College of Letters and Science; and
Geerat Vermeij of the department of earth and planetary sciences, College of Letters and Science.
PHILADELPHIA: Piperlongumine, a chemical compound found in the Indian Long Pepper plant (Piper longum), is known to kill cancerous cells in many tumor types, including brain tumors. Now an international team including researchers from the Perelman Sc
Faculty Represent Fields of Biology, Earth and Planetary Science, Economics, History
by Andy Fell and Karen Nikos-Rose
April 22, 2021
Four professors from the University of California, Davis, have been elected as members of the American Academy of Arts and Sciences. Established in 1780, the academy includes Americans with accomplishments in a wide range of fields, including scientists, artists, performers, poets and political leaders.
The newly elected members from UC Davis are: Robert Feenstra, Department of Economics, College of Letters and Science; Jodi Nunnari, Department of Molecular and Cellular Biology, College of Biological Sciences; Andrés Reséndez, Department of History, College of Letters and Science; and Geerat Vermeij, Department of Earth and Planetary Sciences, College of Letters and Science.
E-Mail
PHILADELPHIA Piperlongumine, a chemical compound found in the Indian Long Pepper plant (Piper longum), is known to kill cancerous cells in many tumor types, including brain tumors. Now an international team including researchers from the Perelman School of Medicine at the University of Pennsylvania has illuminated one way in which the piperlongumine works in animal models and has confirmed its strong activity against glioblastoma, one of the least treatable types of brain cancer.
The researchers, whose findings were published this month in
ACS Central Science, showed in detail how piperlongumine binds to and hinders the activity of a protein called TRPV2, which is overexpressed in glioblastoma in a way that appears to drive cancer progression. The scientists found that piperlongumine treatment radically shrank glioblastoma tumors and extended life in two mouse models of this cancer, and also selectively destroyed glioblastoma cells taken from human patients.